skip to main content
Idioma:
Refinado por: assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Project ECHO Cancer Initiative: a Tool to Improve Care and Increase Capacity Along the Continuum of Cancer Care
Project ECHO Cancer Initiative: a Tool to Improve Care and Increase Capacity Along the Continuum of Cancer Care
Material Type:
Artigo 		Adicionar ao Meu Espaço

Project ECHO Cancer Initiative: a Tool to Improve Care and Increase Capacity Along the Continuum of Cancer Care

Varon, Melissa Lopez ; Baker, Ellen ; Byers, Emily ; Cirolia, Lucca ; Bogler, Oliver ; Bouchonville, Matthew ; Schmeler, Kathleen ; Hariprasad, Roopa ; Pramesh, C. S. ; Arora, Sanjeev

Journal of cancer education, 2021-07, Vol.36 (Suppl 1), p.25-38 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
2
T-independent response mediated by oncolytic tanapoxvirus recombinants expressing interleukin-2 and monocyte chemoattractant protein-1 suppresses human triple negative breast tumors
T-independent response mediated by oncolytic tanapoxvirus recombinants expressing interleukin-2 and monocyte chemoattractant protein-1 suppresses human triple negative breast tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

T-independent response mediated by oncolytic tanapoxvirus recombinants expressing interleukin-2 and monocyte chemoattractant protein-1 suppresses human triple negative breast tumors

Suryawanashi, Yogesh R. ; Zhang, Tiantian ; Woyczesczyk, Helene M. ; Christie, John ; Byers, Emily ; Kohler, Steven ; Eversole, Robert ; Mackenzie, Charles ; Essani, Karim

Medical oncology (Northwood, London, England), 2017-06, Vol.34 (6), p.112, Article 112 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
3
Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy
Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy

Soundararajan, Rama ; Fradette, Jared J ; Konen, Jessica M ; Moulder, Stacy ; Zhang, Xiang ; Gibbons, Don L ; Varadarajan, Navin ; Wistuba, Ignacio I ; Tripathy, Debasish ; Bernatchez, Chantale ; Byers, Lauren A ; Chang, Jeffrey T ; Contreras, Alejandro ; Lim, Bora ; Parra, Edwin Roger ; Roarty, Emily B ; Wang, Jing ; Yang, Fei ; Barton, Michelle ; Rosen, Jeffrey M ; Mani, Sendurai A

Cancers, 2019-05, Vol.11 (5), p.714 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
4
Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma
Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma

Zaidi, Ali H ; Kelly, Lori A ; Kreft, Rachael E ; Barlek, Mark ; Omstead, Ashten N ; Matsui, Daisuke ; Boyd, Natalie H ; Gazarik, Kathryn E ; Heit, Megan I ; Nistico, Laura ; Kasi, Pashtoon M ; Spirk, Tracy L ; Byers, Barbara ; Lloyd, Emily J ; Landreneau, Rodney J ; Jobe, Blair A

BMC cancer, 2016-02, Vol.16 (52), p.52-52, Article 52 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
5
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms
Material Type:
Artigo 		Adicionar ao Meu Espaço

DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms

Yao, James ; Bergsland, Emily ; Aggarwal, Rahul ; Aparicio, Ana ; Beltran, Himisha ; Crabtree, Judy S ; Hann, Christine L ; Ibrahim, Toni ; Byers, Lauren A ; Sasano, Hironobu ; Umejiego, John ; Pavel, Marianne

The oncologist (Dayton, Ohio), 2022-11, Vol.27 (11), p.940-951 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
6
Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC
Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC
Material Type:
Artigo 		Adicionar ao Meu Espaço

Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC

Hong, Lingzhi ; Negrao, Marcelo V. ; Dibaj, Seyedeh S. ; Chen, Runzhe ; Reuben, Alexandre ; Bohac, Jadi M. ; Liu, Xiaoke ; Skoulidis, Ferdinandos ; Gay, Carl M. ; Cascone, Tina ; Mitchell, Kyle G. ; Tran, Hai T. ; Le, Xiuning ; Byers, Lauren A. ; Sepesi, Boris ; Altan, Mehmet ; Elamin, Yasir Y. ; Fossella, Frank V. ; Kurie, Jonathan M. ; Lu, Charles ; Mott, Frank E. ; Tsao, Anne S. ; Rinsurongkawong, Waree ; Lewis, Jeff ; Gibbons, Don L. ; Glisson, Bonnie S. ; Blumenschein, George R. ; Roarty, Emily B. ; Futreal, P. Andrew ; Wistuba, Ignacio I. ; Roth, Jack A. ; Swisher, Stephen G. ; Papadimitrakopoulou, Vassiliki A. ; Heymach, John V. ; Lee, J. Jack ; Simon, George R. ; Zhang, Jianjun

Journal of thoracic oncology, 2020-09, Vol.15 (9), p.1449-1459 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
7
Discovering Synergistic Compounds with BYL-719 in PI3K Overactivated Basal-like PDXs
Discovering Synergistic Compounds with BYL-719 in PI3K Overactivated Basal-like PDXs
Material Type:
Artigo 		Adicionar ao Meu Espaço

Discovering Synergistic Compounds with BYL-719 in PI3K Overactivated Basal-like PDXs

Boyd, David C ; Zboril, Emily K ; Olex, Amy L ; Leftwich, Tess J ; Hairr, Nicole S ; Byers, Holly A ; Valentine, Aaron D ; Altman, Julia E ; Alzubi, Mohammad A ; Grible, Jacqueline M ; Turner, Scott A ; Ferreira-Gonzalez, Andrea ; Dozmorov, Mikhail G ; Harrell, J Chuck

Cancers, 2023-03, Vol.15 (5), p.1582 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
8
Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses
Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses

Owonikoko, Taofeek K. ; Niu, Huifeng ; Nackaerts, Kristiaan ; Csoszi, Tibor ; Ostoros, Gyula ; Mark, Zsuzsanna ; Baik, Christina ; Joy, Anil Abraham ; Chouaid, Christos ; Jaime, Jesus Corral ; Kolek, Vitezslav ; Majem, Margarita ; Roubec, Jaromir ; Santos, Edgardo S. ; Chiang, Anne C. ; Speranza, Giovanna ; Belani, Chandra P. ; Chiappori, Alberto ; Patel, Manish R. ; Czebe, Krisztina ; Byers, Lauren ; Bahamon, Brittany ; Li, Cong ; Sheldon-Waniga, Emily ; Kong, Eric F. ; Williams, Miguel ; Badola, Sunita ; Shin, Hyunjin ; Bedford, Lisa ; Ecsedy, Jeffrey A. ; Bryant, Matthew ; Jones, Sian ; Simmons, John ; Leonard, E. Jane ; Ullmann, Claudio Dansky ; Spigel, David R.

Journal of thoracic oncology, 2020-02, Vol.15 (2), p.274-287 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2016  (1)
  2. 2016Até2016  (1)
  3. 2017Até2018  (1)
  4. 2019Até2020  (3)
  5. Após 2020  (3)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.